CereVasc
PrivateLast Round
Series C
Jun 4, 2026
Est. Valuation
$135M
Total Funding Raised
$198.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
CereVasc is a medical device company that develops minimally invasive endovascular treatments for neurological diseases, including its flagship eShunt System for communicating hydrocephalus.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CereVasc Comparables
Compare CereVasc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| B. Braun SE | 74% | |
| Integra LifeSciences Holdings Corporation | 73% | |
| Medtronic | 72% |
CereVasc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 4, 2026 | ||||
| Series B | May 13, 2024 | ||||
| Series A | Jun 9, 2020 |
Key People
Founding team and executive leadership
CereVasc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Series C, Series B |
| Perceptive Advisors | Series C, Series A, Series B |
| Xontogeny | Series B, Series A |
| Bain Capital, LP | Series B |
| Johnson & Johnson Innovation – JJDC | Series C |
| Johnson & Johnson Innovation - JJDC, Inc. | Series C |
| ATON Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
$85M round led by Piper Sandler & Co.
- May 13, 2024
$70M round led by Bain Capital, LP.
Recent news
Latest coverage and updates
- promotesSep 15, 2026
CereVasc, Inc. promoted Dan Levangie to chairman of the board on Sep 15th '26.
- hiresSep 15, 2026
CereVasc, Inc. hired Tony Kingsley as President and Chief Executive Officer on Sep 15th '26.
- hiresSep 15, 2026
CereVasc, Inc. hired Tony as President and Chief Executive Officer on Sep 15th '26.
- expands_facilitiesJul 31, 2026
CereVasc, Inc. was planning to expand facilities to Massachusetts, United States, Northern America, Americas on Jun 1st '26.
- expands_facilitiesJul 30, 2026
CereVasc, Inc. expanded facilities to Wilmington, Massachusetts, United States, Northern America, Americas on Jul 30th '26.
CereVasc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CereVasc's valuation, stock price, and market status.
Is CereVasc a public or private company?
CereVasc is a private company.
What is the current stock price of CereVasc?
CereVasc is a private company with no public stock price. No recent secondary market data is available.
How much is CereVasc worth (valuation)?
Valuation information for CereVasc is not publicly available.
Can I buy CereVasc stock?
CereVasc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CereVasc's last funding round?
CereVasc's most recent funding round was Series C on June 4, 2026.
Who are the main investors in CereVasc?
Key investors in CereVasc include Bain Capital Life Sciences, Perceptive Advisors, Xontogeny, Bain Capital, LP.
Will CereVasc IPO soon?
No public IPO plans have been announced for CereVasc.
How can I track CereVasc secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CereVasc's secondary market activity and sign up for updates.